Side effects in all analysed clinical trials
Frequency in 3 group СD patients
Frequency in 4 group CD patients
95% CI
p
Acute infusion reaction
2/47
0
-
0.07
Fever
22/47
0
8.1-422.0
<0.001
Serious infectious complications
1/47
3/124
0.09-1.85
0.7
Non-serious infectious complications
12/47
48/124
1.5-23.58
0,66
Malignancy
0
2/124
-
0.93
Lethal cases
0
1
-
0,61
Table 3:
Summary analysis of side effects occurred after MSC injection and in control group of patients with CD.
